InvestorsObserver
×
News Home

Is Greenwich Lifesciences Inc (GLSI) a Leader in the Healthcare Sector?

Wednesday, December 21, 2022 01:30 PM | InvestorsObserver Analysts

Mentioned in this article

Is Greenwich Lifesciences Inc (GLSI) a Leader in the Healthcare Sector?

A rating of 80 puts Greenwich Lifesciences Inc (GLSI) near the top of the Healthcare sector according to InvestorsObserver. Greenwich Lifesciences Inc's score of 80 means that it ranks higher than 80% of stocks in the sector. In addition, its overall score of 36 ranks it higher than 36% of all stocks.

Overall Score - 36
GLSI has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on GLSI!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 36 means the stock is more attractive than 36 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Greenwich Lifesciences Inc Stock Today?

Greenwich Lifesciences Inc (GLSI) stock is trading at $14.24 as of 1:06 PM on Wednesday, Dec 21, a rise of $1.23, or 9.45% from the previous closing price of $13.01. The stock has traded between $13.25 and $14.89 so far today. Volume today is 38,859 compared to average volume of 44,226. Click Here to get the full Stock Report for Greenwich Lifesciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App